Company Filing History:
1 out of 600 
1 out of 417 
Years Active: 2025
Title: Fataneh Majlessipour: Innovator in Growth Treatment
Introduction
Fataneh Majlessipour is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of medicine, particularly in the treatment of idiopathic short stature. Her innovative approach has the potential to change the lives of many individuals facing growth challenges.
Latest Patents
Majlessipour holds a patent for the "Use of FGFR inhibitors for treatment of idiopathic short stature." This invention describes methods for treating idiopathic short stature and includes techniques for increasing a subject's height. The methods involve administering an effective amount of a pan FGFR inhibitor or a selective FGFR inhibitor to the subject. An example of an FGFR inhibitor used in these methods is erdafitinib. She has 1 patent to her name.
Career Highlights
Throughout her career, Fataneh Majlessipour has worked with esteemed institutions such as Cedars-Sinai Medical Center and Children's Hospital Medical Center. Her work in these organizations has allowed her to collaborate with leading professionals in the medical field.
Collaborations
Some of her notable coworkers include Moise Danielpour and Vivian Hwa. Their collaboration has contributed to the advancement of research in growth treatments.
Conclusion
Fataneh Majlessipour's innovative work in the treatment of idiopathic short stature showcases her dedication to improving patient outcomes. Her contributions to the field of medicine are commendable and highlight the importance of innovation in healthcare.